Ohio Public Employees Retirement System (OPERS)’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-11,958
Closed -$69K 2017
2020
Q4
$69K Hold
11,958
﹤0.01% 1713
2020
Q3
$87K Hold
11,958
﹤0.01% 1531
2020
Q2
$42K Buy
+11,958
New +$34.5K ﹤0.01% 1748

Other funds holding CBAY

Ohio Public Employees Retirement System (OPERS)'s CBAY Position: Q1 2021 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Cymabay Therapeutics (CBAY) in Q1 2021, closing a stake of 11,958 shares — an estimated $69K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in CBAY in Q2 2020 and held it in 3 quarters. The position peaked at $87K in Q3 2020. 130 funds tracked by Wall St. Rank hold CBAY as of Q1 2021.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Cymabay Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 11,958 Cymabay Therapeutics shares in Q1 2021, an estimated $69K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Cymabay Therapeutics in Q2 2020 and held it in 3 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Cymabay Therapeutics position peaked at $87K in Q3 2020.
  • 130 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2021.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2021, filed 14 May 2021.